Cannabis Legislation in Slovenia

Current Framework and Future Challenges

Cannabis Legislation in Slovenia

Introduction

Cannabis sativa L. is a plant with a long history of use in medicine, industry, and nutrition. In recent years, Slovenia—like many other European countries—has begun gradually regulating the medical use of cannabis. Despite some progress, the legislation remains only partially defined, posing challenges for the pharmaceutical profession and the healthcare system.

Regulatory Framework

The legal framework governing cannabis in Slovenia is determined by several acts:

Production and Trade in Illicit Drugs Act (ZPPPD)

Official Gazette of the RS, No. 108/99, as amended

Cannabis and its active compounds, including tetrahydrocannabinol (THC), are classified as controlled substances under Schedule II.
Use is permitted for medical, scientific, and educational purposes under conditions prescribed by law.

Regulation on the Classification of Illicit Drugs

Official Gazette of the RS, No. 45/14, 14/17, 64/19

Specifies the list of substances, including THC and other cannabinoids, and defines the conditions for their use.

Medicines Act (ZZdr-2)

Official Gazette of the RS, No. 17/14, as amended

Governs the registration, distribution, and prescription of medicines, including those containing cannabis-derived active substances.

Pharmacy Services Act (ZLD-1)

Official Gazette of the RS, No. 85/16, as amended

Defines the conditions for the dispensing of medicines and magistral preparations that may include cannabis extracts.

In 2017, the Ministry of Health officially authorized the prescription of medicines containing THC for medical purposes. Magistral preparations may be compounded in pharmacies, but only from registered and controlled raw materials.

The use of industrial hemp (THC content up to 0.3%) is permitted under Regulation (EU) No. 1307/2013, provided it is used for food, cosmetic, or industrial purposes, and not for medicinal use.

Summary of the Legal Framework

Medical use: permitted (registered medicines, magistral preparations with THC and CBD).
Recreational use: prohibited.
Industrial hemp: permitted if THC ≤ 0.3%.
Prescription: restricted to authorized physicians; oversight provided by JAZMP and the Ministry of Health.
Traceability and control: mandatory reporting on usage and prescription.

Areas Requiring Further Regulation

To ensure comprehensive governance of cannabis use, Slovenia must:

Establish a legal framework for the cultivation of medical cannabis within the country (currently, only import is permitted).
Define quality standards for magistral preparations and raw materials.
Provide education for physicians and pharmacists on the pharmacological properties and interactions of cannabinoids.
Implement a patient registry and a clinical monitoring system for therapeutic outcomes.
Develop new legislation aligned with EU directives and EMA recommendations.

Conclusion

Through partial liberalization, Slovenia has enabled controlled medical use of cannabis; however, the field remains incompletely regulated. For the pharmaceutical sector, this represents both a challenge and an opportunity—the development of clear legal and professional standards will be essential for ensuring safe and effective cannabinoid-based therapies and for fostering the advancement of new treatment options.

References

Production and Trade in Illicit Drugs Act (ZPPPD) – Official Gazette of the RS, No. 108/99, 44/00, 2/04, 47/04, 93/12.
Regulation on the Classification of Illicit Drugs – Official Gazette of the RS, No. 45/14, 14/17, 64/19.
Medicines Act (ZZdr-2) – Official Gazette of the RS, No. 17/14.
Pharmacy Services Act (ZLD-1) – Official Gazette of the RS, No. 85/16.
Regulation (EU) No 1307/2013.
Ministry of Health of the Republic of Slovenia – Position on the Medical Use of Cannabis (2017).

Contact Us

For inquiries, product information, or partnership opportunities, please reach out to our team.

Get In Touch With Us

How Can We Assist You?

Share the details of your request and our team will respond promptly.

Mail us:
info@farmakem.si
Call us:
+386 262 007 91
Office Hours
Mon–Fri: 8:00 a.m. – 4:00 p.m.

Mail us:
info@farmakem.si
Call us:
+386 262 007 91
Office Hours
Mon–Fri: 8 a.m. – 4 p.m.

Mail us:
info@farmakem.si
Call us:
+386 262 007 91
Office Hours
Mon–Fri: 8 a.m. – 4 p.m.